|
|
Vaccine Detail
|
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine |
| Vaccine Information |
- Vaccine Name: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007460
- Type: Other
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- UL83
gene engineering:
- UL123
gene engineering:
- Type: Recombinant protein preparation
- Description: (Correa, 1988)
- Detailed Gene Information: Click Here.
- UL122
gene engineering:
- Type: Recombinant protein preparation
- Description: (Correa, 1988)
- Detailed Gene Information: Click Here.
- Description: NULL
|
| Host Response |
|
|
| References |
Correa, 1988: Correa A. [Impressions in relation to periodontal tissue]. Revista de la Federacion Odontologica Colombiana. 1988; 38(164); 55-63. [PubMed: 3077513].
Correale et al., 1998: Correale P, Walmsley K, Zaremba S, Zhu M, Schlom J, Tsang KY. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. Journal of immunology (Baltimore, Md. : 1950). 1998; 161(6); 3186-3194. [PubMed: 9743387].
|
|
